Gianluca Severi

University of Firenze
Country flagItaly

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (15)

Background: Current epidemiologic evidence indicates that smoking is associated with a lower endometrial cancer risk. However, it is unknown if this association is causal or confounded. To further elucidate the role of smoking in endometrial cancer risk, we conducted complementary observational and Mendelian randomization (MR) analyses. Methods: The observational analyses included 286,415 participants enrolled in the European Prospective Investigation into Cancer and Nutrition and 179,271 participants in the UK Biobank, and multivariable Cox proportional hazards models were used. In two-sample MR analyses, genetic variants robustly associated with lifetime amount of smoking ( n = 126 variants) and ever having smoked regularly ( n = 112 variants) were selected and their association with endometrial cancer risk (12,906 cancer/108,979 controls from the Endometrial Cancer Association Consortium) was examined. Results: In the observational analysis, lifetime amount of smoking and ever having smoked regularly were associated with a lower endometrial cancer risk. In the MR analysis accounting for body mass index, a genetic predisposition to a higher lifetime amount of smoking was not associated with endometrial cancer risk (OR per 1-SD increment: 1.15; 95% confidence interval: 0.91–1.44). Genetic predisposition to ever having smoked regularly was not associated with risk of endometrial cancer. Conclusions: Smoking was inversely associated with endometrial cancer in the observational analyses, although unsupported by the MR. Additional studies are required to better understand the possible confounders and mechanisms underlying the observed associations between smoking and endometrial cancer. Impact: The results from this analysis indicate that smoking is unlikely to be causally linked with endometrial cancer risk.

Year:

2025

Background: Many studies have shown that socioeconomic position (SEP) is associated with the incidence of malignant tumors at different sites. This study aims to estimate the association between educational level (as proxy for SEP) and cancer incidence and to understand whether the observed associations might be partially explained by lifestyle behaviors. Methods: The analyses were performed on data from the European Prospective Investigation into Cancer and Nutrition (EPIC) study, globally and by sex. We used Cox proportional hazards models together with mediation analysis to disentangle the total effect (TE) of educational level [measured through the Relative Index of Inequality (RII)] on cancer incidence into pure direct (PDE) and total indirect (TIE) effect, unexplained and explained by mediators, respectively. PDE and TIE were then combined to compute the proportions mediated (PM). Results: After an average of 14 years of follow-up, 52,422 malignant tumors were ascertained. Low educated participants showed higher risk of developing stomach, lung, kidney (in women), and bladder (in men) cancers, and, conversely, lower risk of melanoma and breast cancer (in post-menopausal women), when compared with more educated participants. Mediation analyses showed that portions of the TE of RII on cancer could be explained by site-specific related lifestyle behaviors for stomach, lung, and breast (in women). Conclusions: Cancer incidence in Europe is determined at least in part by a socioeconomically stratified distribution of risk factors. Impact: These observational findings support policies to reduce cancer occurrence by altering mediators, such as lifestyle behaviors, particularly focusing on underprivileged strata of the population.

Year:

2025

Descriptive analyses according to sex and country, Analyses to verify mediation assumptions. Supplementary Table S1 Descriptive analyses of the male EPIC population in terms of demographic, clinical, and risk/protective factors for cancer, according to the Relative Index of Inequality Tertiles (RIIT). Supplementary Table S2 Descriptive analyses of the female EPIC population in terms of demographic, clinical, and risk/protective factors for cancer, according to the Relative Index of Inequality Tertiles (RIIT). Supplementary Table S3 Descriptive analyses of the EPIC population in terms of demographic, clinical, and lifestyle risk/protective factors for cancer, according to sex and country. Supplementary Table S4 Multinomial logistic, logistic, and linear regressions results in terms of Odds Ratios (OR) or linear coefficient (beta) showing the association between the Relative Index of Inequality Tertiles (RIIT) and putative mediators. Supplementary Table S5 Cox Proportional-Hazard models showing the Hazard Ratio (HR) for the site-specific putative mediators on the incidence of the tumour at the relative site.

Year:

2025

Effects (pure direct effect, total indirect effect, and total effect) estimated as function of time to event (years), considering site-specific cancer occurrence as outcome, RelativeIndex of Inequality Tertiles (RIIT) as exposure, age, and country (and sex) as confounders, site-specific lifestyle-behavioural factors as mediators.

Year:

2025

Supplementary Table 7 shows the Mendelian randomization estimates for the potential causal effect of genetic liability to allergic diseases and asthma on colorectal cancer risk; leave one genetic variant out sensitivity analyses.

Year:

2025

Supplementary Table 4 shows the genome-wide significant variants related to (a) allergic diseases (asthma, hay fever, or eczema), (b) early-onset asthma, (c) later-onset asthma, (d) atopic asthma, and (e) hay fever or eczema and their association with other traits in previous genome-wide association studies.

Year:

2025

Supplementary Table 2 shows the genetic variant overlap (same variants or variants in LD R2>0.001 between exposures) for the three exposures tested in our Mendelian randomization analyses (i.e., genetic liability to allergic diseases and their overlap with variants associated with asthma-related phenotypes and hay fever/allergic rhinitis or eczema).

Year:

2025

Background: The tumor immunosurveillance theory supports that allergic conditions could decrease cancer risk. However, observational evidence yielded inconsistent results for the association between allergic diseases and colorectal cancer risk. We used Mendelian randomization (MR) to examine potential causal associations of allergies with the risk of overall and early-onset colorectal cancer. Methods: Genome-wide association study summary statistical data were used to identify genetic variants associated with allergic diseases ( N variants = 65) and individual allergic conditions (asthma, hay fever/allergic rhinitis, and eczema). Using two-sample MR, we examined these variants in relation to incident overall ( N cases = 52,775 cases) and early-onset colorectal cancer ( N cases = 6,176). The mediating role of white blood cells was examined using multivariable MR. Results: In inverse-variance–weighted models, genetic liability to allergic diseases was inversely associated with overall {OR per log (odds) = 0.90 [95% confidence interval (CI), 0.85–0.96]; P P = 0.01]. Similar inverse associations were found for hay fever/allergic rhinitis or eczema, whereas no evidence of association was found between liability to asthma-related phenotypes and colorectal cancer risk. Multivariable MR adjustment for eosinophils weakened the inverse associations for liability to allergic diseases for overall [OR = 0.96 (95% CI, 0.89–1.03); P = 0.26] and early-onset colorectal cancer [OR = 0.86 (95% CI, 0.73–1.01); P = 0.06]. Conclusions: Our study supports a potential causal association between liability to allergic diseases, specifically hay fever/allergic rhinitis or eczema, and colorectal cancer, possibly at least in part mediated via eosinophil counts. Impact: Our results provide evidence that allergic responses may also have a role in immunosurveillance against colorectal cancer.

Year:

2025

Supplementary Table 3 shows the number of cancer cases and controls in the Mendelian randomization study of genetic liability to allergic diseases and asthma-related phenotypes and risk of colorectal cancer.

Year:

2025

Supplementary figure S2: Flowchart recapping the different stages of the analysis The flowchart describes schematically the different stages of our analysis starting from the normalisation of the metabolomic data, the determination of the metabolomic signature in the controls and finally the derivation of the metabolomic signature in the CRC nested case control study and the evaluation of any mediating effects Abbreviations: CRC: colorectal cancer; PLS: partial least squares

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2020

Collaborators (48)

Fabian Eichelmann

German Institute of Human Nutrition

GERMANY
View details

Annika Idahl

Umea University

SWEDEN
View details

Marc Gunter

International Agency for Research on Cancer

FRANCE
View details

Konstantinos K. Tsilidis

-

UNITED KINGDOM
View details

Ben Lacey

-

UNITED KINGDOM
View details

Emma Vincent

Academic , Professor of Molecular Metabolism

University of Bristol

UNITED KINGDOM
View details

Naomi Allen

University of Oxford

UNITED KINGDOM
View details

Carlotta Sacerdote

Docenti di ruolo di Ia fascia

Università degli Studi del Piemonte Orientale Amedeo Avogadro

ITALY
View details

Kristin Benjaminsen Borch

Associate professor and Research group leader Systems Epidemiology

UiT The Arctic University of Norway

NORWAY
View details

Anne Tjonneland

Professor

Københavns Universitet

DENMARK
View details

Fulvio Ricceri

University of Turin

ITALY
View details

Christina Dahm

VIP, Professor

Aarhus University

DENMARK
View details

Tracy O'Mara

Team Head

QIMR Berghofer Medical Research Institute

AUSTRALIA
View details

Zhaozhong Zhu

Massachusetts General Hospital

UNITED STATES
View details

Sophia Harlid

Umea University

SWEDEN
View details

Kim Overvad

Aarhus University

DENMARK
View details

Matthias B. Schulze

German Institute of Human Nutrition

GERMANY
View details

Wei Zheng

-

UNITED STATES
View details

Elizabeth Platz

Professor

Johns Hopkins University

UNITED STATES
View details

Heather Ward

Imperial College London

UNITED KINGDOM
View details

Sarah Lewis

Senior Lecturer

University of Bristol

UNITED KINGDOM
View details

Inger Torhild Gram

Professor

UiT The Arctic University of Norway

NORWAY
View details

Adrian Hugo Aginagalde Llorente

Associate lecturer / profesor asociado

Universidad de Deusto

SPAIN
View details

Claudia Giachino

University of Turin

ITALY
View details

Manuela Bergmann

senior scientist

German Institute of Human Nutrition

GERMANY
View details

Sun-Seog Kweon

Chonnam National University

SOUTH KOREA
View details

Robert C. Grant

University Health Network

CANADA
View details

Bethany Van Guelpen

Umea University

SWEDEN
View details

Dagfinn Aune

Associate Professor

-

NORWAY
View details

Li Li

University of Virginia

UNITED STATES
View details

Philip Haycock

Senior Lecturer in Cancer Epidemiology

University of Bristol

UNITED KINGDOM
View details

Xia Jiang

Karolinska Institutet

SWEDEN
View details

Tonje Braaten

Associate professor II

Nord University

NORWAY
View details

Rebecca Richmond

Academic , Associate Professor in Molecular Epidemiology

University of Bristol

UNITED KINGDOM
View details

Alicia Heath

Imperial College London

UNITED KINGDOM
View details

Renée Fortner

Head of Division

Deutsches Krebsforschungszentrum

GERMANY
View details

Vittorio Perduca

Université Paris Cité

FRANCE
View details

Elom K Aglago

Imperial College London

UNITED KINGDOM
View details

Nicola Bondonno

Adjunct Lecturer

Edith Cowan University

AUSTRALIA
View details

Aurora Perez-Cornago

University of Oxford

UNITED KINGDOM
View details

Marina Kvaskoff

-

FRANCE
View details

Mattias Johansson

Scientist

International Agency for Research on Cancer

FRANCE
View details

Pietro Ferrari

Branch Head

International Agency for Research on Cancer

FRANCE
View details

alessandra macciotta

University of Turin

ITALY
View details

Daniel D. Buchanan

Senior Research Fellow

University of Melbourne

AUSTRALIA
View details

Christopher Li

Fred Hutchinson Cancer Research Center

UNITED STATES
View details

Domenico PALLI

Head

Institute for Cancer Research, Prevention and Clinical Network-ISPRO

ITALY
View details

Stephen Gruber

Professor

City Of Hope National Medical Center

UNITED STATES
View details